Federal Register / Vol. 72, No. 14 / Tuesday, January 23, 2007 / Notices 2893 

Chair of the Council (or the Chair-elect) 

or to the member of the Council who 

most recently served as the Chair; and 

one additional consecutive 2-year term 

may be served by any member of the 

Council who has no employment, 

governance, or financial affiliation with 

any donor center, recruitment 

organization, transplant center, or cord 

blood bank. A member of the Council 

may continue to serve after the 

expiration of the term of such member 

until a successor is appointed. In order 

to ensure the continuity of the Council, 

the Council shall be appointed so that 

each year the terms of approximately 

one-third of the members of the Council 

expires. Any member of the Council 

who has an employment, governance, or 

financial affiliation with a donor center, 

recruitment organization, transplant 

center, or cord blood bank will be 

prohibited from participating in any 

decision that materially affects the 

donor center, recruitment organization, 

transplant center, or cord blood bank. 

The number of members with such 

affiliations on the Council shall be 

limited. Meetings shall be held up to 3 

times per year at the call of the 

Designated Federal Official or designee 

who shall approve the agenda and shall 

be present at all meetings. 

A vacancy on the Council shall be 

filled in the manner in which the 

original appointment was made and 

shall be subjected to any conditions that 

applied with respect to the original 

appointment. An individual chosen to 

fill a vacancy shall be appointed for the 

remainder of the term of the member 

replaced. The vacancy shall not affect 

the power of the remaining members to 

execute the duties of the Council. 

All members of HRSA advisory 

committees shall adhere to the conflict 

of interest rules applicable to Special 

Government Employees as such 

employees are defined in 18 U.S.C. 

section 202(a). These rules include 

relevant provisions in 18 U.S.C. related 

to criminal activity, Standards of Ethical 

Conduct for Employees of the Executive 

Branch (5 CFR part 2635), and Executive 

Order 12674 (as modified by Executive 

Order 12731). 

Management and support services 

shall be provided by the Director, 

Division of Transplantation, Healthcare 

Systems Bureau, HRSA. 

III. Compensation 

Members shall be paid at a rate of 

$200 for each day they are engaged in 

the performance of their duties as 

members of the Council. Members shall 

receive per diem and travel expenses as 

authorized by 5 U.S.C. 5703, as 

amended, for persons employed 

intermittently in the Government 

service. Members who are officers or 

employees of the United States 

Government shall not receive 

compensation for service on the 

Council. 

IV. Nominations 

HHS will consider nominations of all 

qualified individuals to ensure that the 

Advisory Council includes the areas of 

subject matter expertise noted above 

(see ‘‘Structure’’). Individuals may 

nominate themselves or other 

individuals, and professional 

associations and organizations may 

nominate one or more qualified persons 

for membership on the Advisory 

Council. 

Nominations shall state that the 

nominee is willing to serve as a member 

of the Council. Potential candidates will 

be asked to provide detailed information 

concerning financial interests, 

consultancies, research grants, and/or 

contracts that might be affected by 

recommendations of the Council to 

permit evaluation of possible sources of 

conflicts of interest. In addition, 

nominees will be asked to provide 

detailed information concerning any 

employment, governance, or financial 

affiliation with any donor centers, 

recruitment organizations, transplant 

centers, and/or cord blood banks. 

A nomination package should include 

the following information for each 

nominee: (1) A letter of nomination 

stating the name, affiliation, and contact 

information for the nominee, the basis 

for the nomination (i.e., what specific 

attributes recommend him/her for 

service in this capacity), and the 

nominee’s field(s) of expertise; (2) a 

biographical sketch of the nominee and 

a copy of his/her curriculum vitae; and 

(3) the name, return address, e-mail 

address, and daytime telephone number 

at which the nominator can be 

contacted. 

HHS has special interest in assuring 

that women, minority groups, and the 

physically disabled are adequately 

represented on advisory committees; 

and therefore, extends particular 

encouragement to nominations for 

appropriately qualified female, 

minority, or disabled candidates. HHS 

also encourages geographic diversity in 

the composition of the Council. 

All nomination information should be 

provided in a single, complete package 

within 30 days of the publication of this 

notice. All nominations for membership 

should be sent to the Executive 

Secretary of the Council at the address 

provided above. 

Dated: January 16, 2007. 

Elizabeth M. Duke, 

Administrator. 

[FR Doc. E7–891 Filed 1–22–07; 8:45 am] 

BILLING CODE 4165–15–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Fogarty International Center; Notice of 

Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of a meeting of the 

Fogarty International Center Advisory 

Board. 

The meeting will be open to the 

public as indicated below, with 

attendance limited to space available. 

Individuals who plan to attend and 

need special assistance, such as sign 

language interpretation or other 

reasonable accommodations, should 

notify the Contact Person listed below 

in advance of the meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications 

and/or contract proposals and the 

discussions could disclose confidential 

trade secrets or commercial property 

such as patentable material, and 

personal information concerning 

individuals associated with the grant 

applications and/or contract proposals, 

the disclosure of which would 

constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Fogarty International 

Center Advisory Board. 

Date: February 5–6, 2007. 

Closed: February 5, 2007, 1 p.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications and/or proposals. 

Place: National Institutes of Health, 

Lawton Chiles International House, Bethesda, 

MD 20892. 

Open: February 6, 2007, 8:30 a.m. to 5 p.m. 

Agenda: Discussions will focus on Fogarty 

International Center’s early draft of the 

Strategic Plan. 

Place: National Institutes of Health, 

Lawton Chiles International House, Bethesda, 

MD 20892. 

Contact Person: Jean L. Flagg-Newton, 

PhD, Special Assistant to the Director, FIC, 

Fogarty International Center, National 

Institutes of Health, 9000 Rockville Pike, 

Building 31, Room B2C29, Bethesda, MD 

20892, (301) 496–2968, 

flaggnej@mail.nih.gov. 

Any interested person may file written 

comments with the committee by forwarding 

the statement to the Contact Person listed on 

mstockstill on PROD1PC70 with NOTICES

2894 Federal Register / Vol. 72, No. 14 / Tuesday, January 23, 2007 / Notices 

this notice. The statement should include the 

name, address, telephone number and when 

applicable, the business or professional 

affiliation of the interested person. 

In the interest of security, NIH has 

instituted stringent procedures for entrance 

onto the NIH campus. All visitor vehicles, 

including taxicabs, hotel, and airport shuttles 

will be inspected before being allowed on 

campus. Visitors will be asked to show one 

form of identification (for example, a 

government-issued photo ID, driver’s license, 

or passport) and to state the purpose of their 

visit. 

Information is also available on the 

Institute’s/Center’s home page: www.nih.gov/ 

fic/about/advisory.html, where an agenda 

and any additional information for the 

meeting will be posted when available. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.106, Minority International 

Research Training Grant in the Biomedical 

and Behavioral Sciences; 93.154, Special 

International Postdoctoral Research Program 

in Acquired Immunodeficiency Syndrome; 

93.168, International Cooperative 

Biodiversity Groups Program, 93.934, Fogarty 

International Research Collaboration Award; 

93.989, Senior International Fellowship 

Awards Program, National Institutes of 

Health, HHS) 

Dated: January 17, 2007. 

David Clary, 

Acting Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 07–262 Filed 1–22–07; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Cancer Institute Notice of 

Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of the following 

meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel, K23 

Application. 

Date: February 12, 2007. 

Time: 4 p.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6116 

Executive Boulevard, 8109, Bethesda, MD 

20892, (Telephone Conference Call). 

Contact Person: Sonya Roberson, PhD, 

Scientific Review Administrator, Resources 

and Training Review Branch, Division of 

Extramural Activities, National Cancer 

Institute, 6116 Executive Blvd., Room 8109, 

Bethesda, MD 20892, 301–594–1182, 

robersos@mail.nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.392, Cancer Construction; 

93.393, Cancer Cause and Prevention 

Research; 93.394, Cancer Detection and 

Diagnosis Research; 93.395, Cancer 

Treatment Research; 93.396, Cancer Biology 

Research; 93.397, Cancer Centers Support; 

93.398, Cancer Research Manpower; 93.399, 

Cancer Control, National Institutes of Health, 

HHS) 

Dated: January 16, 2007. 

David Clary, 

Acting Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 07–263 Filed 1–22–07; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Cancer Institute; Notice of 

Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of the meeting of the 

National Cancer Advisory Board. 

The meeting will be open to the 

public as indicated below, with 

attendance limited to space available. 

Individuals who plan to attend and 

need special assistance, such as sign 

language interpretation or other 

reasonable accommodations, should 

notify the Contact Person listed below 

in advance of the meeting. 

A portion of the meeting will be 

closed to the public in accordance with 

the provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Cancer 

Advisory Board. 

Date: February 6, 2007, 8 a.m. to 4:15 p.m. 

Agenda: Program reports and 

presentations; Business of the Board. 

Place: National Cancer Institute, 9000 

Rockville Pike, Building 31, C Wing, 6th 

Floor, Conference Room 10, Bethesda, MD 

20892. 

Contact Person: Dr. Paulette S. Gray, 

Executive Secretary, National Cancer 

Institute, National Institutes of Health, 6116 

Executive Boulevard, 8th Floor, Room 8001, 

Bethesda, MD 20892–8327, (301) 496–5147. 

Name of Committee: National Cancer 

Advisory Board. 

Closed: February 6, 2007, 4:15 p.m. to 5:30 

p.m. 

Agenda: Review of grant applications. 

Contact Person: Dr. Paulette S. Gray, 

Executive Secretary, National Cancer 

Institute, National Institutes of Health, 6116 

Executive Boulevard, 8th Floor, Room 8001, 

Bethesda, MD 20892–8327, (301) 496–5147. 

This notice is being published less than 15 

days prior to meeting due to scheduling 

conflicts. 

Any interested person may file written 

comments with the committee by forwarding 

the statement to the Contact Person listed on 

this notice. The statement should include the 

name, address, telephone number and when 

applicable, the business or professional 

affiliation of the interested person. 

Information is also available on the 

Institute’s/Center’s home page: 

deainfo.nci.nih.gov/advisory/ncab.htm, 

where an agenda and any additional 

information for the meeting will be posted 

when available. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.392, Cancer Construction; 

93.393, Cancer Cause and Prevention 

Research; 93.394, Cancer Detection and 

Diagnosis Research; 93.395, Cancer 

Treatment Research; 93.396, Cancer Biology 

Research; 93.397, Cancer Centers Support; 

93.398, Cancer Research Manpower; 93.399, 

Cancer Control, National Institutes of Health, 

HHS) 

Dated: January 17, 2007. 

David Clary, 

Acting Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 07–264 Filed 1–22–07; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HOMELAND 

SECURITY 

Federal Emergency Management 

Agency 

Agency Information Collection 

Activities: Proposed Collection; 

Comment Request 

AGENCY: Federal Emergency 

Management Agency, DHS. 

ACTION: Notice and request for 

comments. 

SUMMARY: The Federal Emergency 

Management Agency, as part of its 

continuing effort to reduce paperwork 

mstockstill on PROD1PC70 with NOTICES